🇺🇸 FDA
Pipeline program

Descartes-08

241-59-88

Phase 1 mab terminated

Quick answer

Descartes-08 for Multiple Myeloma is a Phase 1 program (mab) at Cartesian Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Cartesian Therapeutics
Indication
Multiple Myeloma
Phase
Phase 1
Modality
mab
Status
terminated

Clinical trials